Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Evonik Industries

Tracked across 4 events · 29 articles · First seen Jul 08, 2026 · Last active Sep 17, 2026

Sentiment
19
Attention
3
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 15
Business
Impact: Evonik is the investing company; the $100M upgrade enhances its U.S. drug substance manufacturing capabilities, supporting long-term growth and asset balancing.
Jul 08, 2026 · 9 articles
2 40
Business
Impact: Evonik is the primary investor, committing over 150 million CAD to expand its lipid-based drug delivery manufacturing capacity in Vancouver, strengthening its position in the growing LNP market.
Aug 27, 2026 · 8 articles
3 20
Business
Impact: Evonik raised its full-year profit guidance, reflecting benefits from Middle East conflict-related supply disruptions.
Jul 20, 2026 · 6 articles
1 0
Business
CordenPharma, a global pharmaceutical contract development and manufacturing organization (CDMO) backed by private equity firm Astorg, announced the appointment of Dr. Jean-Luc Herbeaux as Chief Executive Officer effective 1 October 2026. Herbeaux succeeds Dr. Michael…
Impact: Evonik is mentioned only as a former employer where Herbeaux held senior roles before joining Hovione. It has no direct operational role in the transition.
Sep 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Evonik Industries live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.